Register   |   Log In Contact Us
Or login with one of the following

Log in

 

Prostate Cancer

Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use - Abstract

BACKGROUND: The neutrophil-lymphocyte ratio (NLR), proposed as an indicator of cancer-related inflammation, has known prognostic value in prostate cancer.

Read more...

Prostate cancer in patients from rural and suburban areas - PSA value, Gleason score and presence of metastases in bone scan - Abstract

INTRODUCTION: Prostate cancer is the second most common neoplasm among men both worldwide and in Poland.

Read more...

#GU15 - Place of short-term androgen deprivation therapy in intermediate-risk prostate cancer treated with radiotherapy: A phase III trial - Session Highlights

ORLANDO, FL, USA (UroToday.com) - The role of short-term androgen deprivation (STADT) in combination with radiation therapy (RT) for patents with intermediate-risk prostate cancer is controversial.

Read more...

Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: Volumetric and dosimetric comparison to the RTOG guidelines - Abstract

Background: Recurrence rates following radiotherapy for prostate cancer in the post-operative adjuvant or salvage setting remain substantial.

Read more...

Prostate cancer screening: And yet it moves! - Abstract

The debate of prostate cancer (PCa) screening has been shaped over decades.

Read more...

Prostate cancer prevalence in New South Wales Australia: A population-based study - Abstract

BACKGROUND: Information on the current and future numbers of Australian men living with prostate cancer is limited.

Read more...

#GU15 - Prostate Cancer Keynote: Can epigenetic alterations in human cancers be exploited for cancer screening, detection, diagnosis and treatment? - Session Highlights

ORLANDO, FL, USA (UroToday.com) - William Nelson, MD, PhD started this session by discussing how new advances in genome sequencing technologies have allowed for the development of more individualized selection of treatment in oncology.

Read more...

Prevalence of prostatic calcification subtypes and association with prostate cancer - Abstract

OBJECTIVE: To evaluate the prevalence and to classify prostatic calcification on transrectal ultrasonography (TRUS) and correlate the findings with histology.

Read more...

#GU15 - Prostate cancer: Year in review - Session Highlights

ORLANDO, FL, USA (UroToday.com) - In 2014, there were 233 000 new cases of prostate cancer, with patients being of a median age of 66-years-old.

Read more...

#GU15 - ASCENDE-RT: A multicenter, randomized trial of dose-escalated external beam radiation therapy (EBRT-B) versus low-dose-rate brachytherapy (LDR-B) for men with unfavorable-risk localized prostate cancer - Session Highlights

ORLANDO, FL, USA (UroToday.com) - In this session, Dr. Scott Tyldesley presented data from the Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (ASCENDE-RT) study from Canada, a randomized trial comparing the use of dose-escalated external beam radiation therapy (DE-EBRT) and low-dose-rate-brachytherapy (LDR-B) in men with intermediate- and high-risk prostate cancer.

Read more...